Manulife (Manufacturers Life Insurance)
ANIP icon

Manulife (Manufacturers Life Insurance)’s ANI Pharmaceuticals ANIP Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$885K Buy
10,688
+1,111
+12% +$89.1K ﹤0.01% 2021
2026
Q1 		$736K Buy
9,577
+143
+2% +$11.2K ﹤0.01% 1988
2025
Q4 		$745K Sell
9,434
-161
-2% -$13.9K ﹤0.01% 1998
2025
Q3 		$879K Buy
9,595
+166
+2% +$13.5K ﹤0.01% 1922
2025
Q2 		$615K Sell
9,429
-175
-2% -$11.4K ﹤0.01% 2070
2025
Q1 		$643K Buy
9,604
+604
+7% +$36.1K ﹤0.01% 2014
2024
Q4 		$498K Sell
9,000
-291
-3% -$16.7K ﹤0.01% 2243
2024
Q3 		$554K Sell
9,291
-207
-2% -$12.6K ﹤0.01% 2232
2024
Q2 		$605K Buy
9,498
+1,211
+15% +$78.6K ﹤0.01% 2123
2024
Q1 		$573K Buy
8,287
+2,607
+46% +$157K ﹤0.01% 2148
2023
Q4 		$313K Buy
5,680
+245
+5% +$13.5K ﹤0.01% 2393
2023
Q3 		$316K Buy
5,435
+225
+4% +$13K ﹤0.01% 2354
2023
Q2 		$280K Buy
5,210
+139
+3% +$6.16K ﹤0.01% 2406
2023
Q1 		$201K Hold
5,071
– – ﹤0.01% 2567
2022
Q4 		$204K Buy
+5,071
New +$190K ﹤0.01% 2567
2022
Q1 		– Sell
-5,682
Closed -$262K – 3073
2021
Q4 		$262K Buy
+5,682
New +$244K ﹤0.01% 2711
2021
Q3 		– Sell
-6,377
Closed -$224K – 3147
2021
Q2 		$224K Sell
6,377
-120
-2% -$4.08K ﹤0.01% 3019
2021
Q1 		$235K Buy
+6,497
New +$203K ﹤0.01% 2780
2020
Q2 		– Sell
-6,001
Closed -$244K – 2842
2020
Q1 		$244K Buy
6,001
+393
+7% +$20.9K ﹤0.01% 2206
2019
Q4 		$346K Sell
5,608
-242
-4% -$16K ﹤0.01% 2257
2019
Q3 		$423K Sell
5,850
-22
-0.4% -$1.65K ﹤0.01% 2118
2019
Q2 		$483K Buy
5,872
+2,788
+90% +$198K ﹤0.01% 2072
2019
Q1 		$218K Buy
+3,084
New +$181K ﹤0.01% 2393
2018
Q3 		– Sell
-6,255
Closed -$418K – 2961
2018
Q2 		$418K Buy
6,255
+59
+1% +$3.68K ﹤0.01% 2530
2018
Q1 		$361K Sell
6,196
-84
-1% -$5.33K ﹤0.01% 2566
2017
Q4 		$405K Sell
6,280
-94
-1% -$5.85K ﹤0.01% 2467
2017
Q3 		$335K Sell
6,374
-119
-2% -$5.67K ﹤0.01% 2566
2017
Q2 		$304K Buy
6,493
+15
+0.2% +$724 ﹤0.01% 2678
2017
Q1 		$321K Buy
6,478
+838
+15% +$47K ﹤0.01% 2497
2016
Q4 		$342K Buy
5,640
+7
+0.1% +$428 ﹤0.01% 2383
2016
Q3 		$374K Sell
5,633
-149
-3% -$9.32K ﹤0.01% 2270
2016
Q2 		$323K Buy
5,782
+239
+4% +$11.6K ﹤0.01% 2326
2016
Q1 		$179K Buy
5,543
+159
+3% +$5.39K ﹤0.01% 2679
2015
Q4 		$243K Hold
5,384
– – ﹤0.01% 2498
2015
Q3 		$212K Buy
5,384
+138
+3% +$7.85K ﹤0.01% 2600
2015
Q2 		$325K Buy
5,246
+474
+10% +$28.2K ﹤0.01% 2444
2015
Q1 		$298K Buy
4,772
+68
+1% +$4.14K ﹤0.01% 2435
2014
Q4 		$265K Buy
4,704
+439
+10% +$19.4K ﹤0.01% 2451
2014
Q3 		$120K Sell
4,265
-305
-7% -$9.14K ﹤0.01% 2995
2014
Q2 		$158K Buy
4,570
+4,482
+5,093% +$141K ﹤0.01% 2899
2014
Q1 		$3K Sell
88
-404
-82% -$10.7K ﹤0.01% 3573
2013
Q4 		$10K Buy
492
+392
+392% +$5.08K ﹤0.01% 3356
2013
Q3 		$1K Buy
+100
New +$721 ﹤0.01% 3578

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ANIP Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its ANI Pharmaceuticals (ANIP) stake by 12% in Q2 2026, buying an estimated $89.1K and bringing the position to 10,688 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #2021.

Manulife (Manufacturers Life Insurance) first reported a position in ANIP in Q3 2013 and has held it in 43 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 10,688 shares of ANI Pharmaceuticals worth $885K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 1,111 ANI Pharmaceuticals shares in Q2 2026, an estimated $89.1K.
  • ANI Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2021 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in ANI Pharmaceuticals in Q3 2013 and has held it in 43 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.